Richard Pzena's MRK Position Overview
Richard Pzena (via Pzena Investment Management LLC) currently holds 3,324 shares of Merck & Co., Inc. (MRK) worth $278,983, representing 0.00% of the portfolio. First purchased in 2016-Q1, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Richard Pzena has maintained a strategic position in MRK, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2018, adding 3.02 M shares. Largest reduction occurred in Q1 2019, reducing 1.85 M shares.
Analysis based on 13F filings available since 2013 Q2
Richard Pzena's Merck & Co (MRK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Merck & Co (MRK) Trades by Richard Pzena
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2016 | +965,591 | New Buy | 965,591 | $50.49 |
| Q2 2016 | +517,738 | Add 53.62% | 1.48 M | $54.97 |
| Q3 2016 | -7,034 | Reduce 0.47% | 1.48 M | $59.55 |
| Q4 2016 | -154,921 | Reduce 10.49% | 1.32 M | $56.17 |
| Q1 2017 | -455,482 | Reduce 34.47% | 865,892 | $60.63 |
| Q2 2017 | -1,355 | Reduce 0.16% | 864,537 | $61.15 |
| Q3 2017 | +728,380 | Add 84.25% | 1.59 M | $61.10 |
| Q4 2017 | +126,352 | Add 7.93% | 1.72 M | $53.69 |
| Q1 2018 | +3.02 M | Add 175.79% | 4.74 M | $51.98 |
| Q2 2018 | +398,141 | Add 8.40% | 5.14 M | $57.92 |
| Q3 2018 | -90,732 | Reduce 1.77% | 5.05 M | $67.69 |
| Q4 2018 | -1.19 M | Reduce 23.60% | 3.86 M | $72.91 |
| Q1 2019 | -1.85 M | Reduce 48.08% | 2 M | $79.36 |
| Q2 2019 | -678,918 | Reduce 33.90% | 1.32 M | $80.01 |
| Q3 2019 | -517,515 | Reduce 39.09% | 806,354 | $80.32 |
| Q4 2019 | -744,720 | Reduce 92.36% | 61,634 | $86.79 |
| Q1 2020 | -34,807 | Reduce 56.47% | 26,827 | $73.43 |
| Q2 2020 | -26,827 | Sold Out | 0 | $0.00 |
| Q1 2021 | +8,956 | New Buy | 8,956 | $73.58 |
| Q2 2021 | -1,337 | Reduce 14.93% | 7,619 | $77.83 |
| Q4 2021 | -734 | Reduce 9.63% | 6,885 | $76.69 |
| Q1 2022 | -1,793 | Reduce 26.04% | 5,092 | $82.09 |
| Q2 2022 | +2,043 | Add 40.12% | 7,135 | $91.10 |
| Q3 2022 | -710 | Reduce 9.95% | 6,425 | $86.07 |
| Q4 2022 | -6,425 | Sold Out | 0 | $0.00 |
| Q4 2024 | +2,898 | New Buy | 2,898 | $99.48 |
| Q1 2025 | -2,898 | Sold Out | 0 | $0.00 |
| Q2 2025 | +3,324 | New Buy | 3,324 | $79.16 |
Richard Pzena's Merck & Co Investment FAQs
Richard Pzena first purchased Merck & Co., Inc. (MRK) in Q1 2016, acquiring 965,591 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Richard Pzena has held Merck & Co., Inc. (MRK) for 30 quarters since Q1 2016.
Richard Pzena's largest addition to Merck & Co., Inc. (MRK) was in Q1 2018, adding 4,741,603 shares worth $246.45 M.
According to the latest 13F filing for Q3 2025, Richard Pzena's firm, Pzena Investment Management LLC, owns 3,324 shares of Merck & Co., Inc. (MRK), valued at approximately $278,983.
As of the Q3 2025 filing, Merck & Co., Inc. (MRK) represents approximately 0.00% of Richard Pzena's publicly disclosed stock portfolio, making it one of their key holdings.
Richard Pzena's peak holding in Merck & Co., Inc. (MRK) was 5,139,744 shares, as reported at the end of Q2 2018.